BioSpace News Archive

BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lannett Company, Inc..

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Teva Pharmaceuticals Industries Limited.

Haemonetics Corporation announced that it received 510 clearance from the U.S. Food and Drug Administration to expand the medical indication of its TEG® 6s Hemostasis Analyzer System for use in adult trauma settings.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the closing of its upsized underwritten public offering of 4,312,500 shares of its common stock at a public offering price of $21.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 562,500 shares of common stock in this offering.

Circuit Clinical™, one of the nation’s largest integrated research organizations dedicated to empowering patients to choose clinical research as a care option, today announced a groundbreaking strategic partnership with CUBRC, a company specializing in advanced data analytics, information fusion and biomedical sciences

Health Carousel, a premier provider of healthcare workforce solutions, today announced the acquisition of Lucidity, one of the leading technology platforms that connects physicians seeking part-time or temporary work directly with medical practices looking to fill open shifts.

Evolent Health (NYSE: EVH), a company providing an integrated value-based care platform to the nation’s leading provider and payer organizations, today announced it will host its fourth annual Investor and Analyst Day on Thursday, May 30, 2019, in New York City.